cagrisema cagrilintide semaglutide phase 3 results 2024 2025 REDEFINE 1 Trial Novo's Phase 3 CagriSema results – Novo Nordisk affirms 25% weight-loss

Out of the 66 new medications or vaccines that were approved this year, ENCORE sites conducted seven of those clinical trials

GLP-1s work like finding that perfect volume setting: just enough to keep you company without drowning out your thoughts

Mol Pharmacol 54, 111317

Currently, studies of GLP-1s for PCOS are inconclusive due to small sample population and heterogenicity between trials

[PubMed: 9873204] 196

Drucker is a scientist and endocrinologist at the University of Toronto who has dedicated his career to understanding the universe of hormones in the body, which do everything from regulating appetite to helping with digestion